-
Advertisement
Coronavirus China
OpinionLetters

Letters | In reopening, China should provide more reliable Covid data

  • Readers discuss the successes and gaps in Chinese pandemic policy, and the prospect of mainland music fans rushing to Hong Kong

Reading Time:2 minutes
Why you can trust SCMP
10
Travellers wearing masks prepare to catch trains at the West Railway Station in Beijing on January 6. Photo: AP
Letters
Feel strongly about these letters, or any other aspects of the news? Share your views by emailing us your Letter to the Editor at [email protected] or filling in this Google form. Submissions should not exceed 400 words, and must include your full name and address, plus a phone number for verification.
I refer to the letter, “China should buy West’s mRNA shots” (January 4).

The World Health Organization has said trials showed two doses of Sinovac vaccine having a 51 per cent protection rate against Covid infection, and 100 per cent against severe illness. In Hong Kong, real-world data might suggest that the BioNTech mRNA vaccine has a higher protection rate, but the fact that Sinovac has been administered to more elderly people should be taken into account.

Advertisement
To be able to claim one vaccine is superior to the other, a properly designed head-to-head clinical trial has to be conducted. Currently, there is no head-to-head data available on Western mRNA and Chinese vaccines. Chinese vaccine makers have multiple vaccines with different mechanisms of action in the pipeline that have either been approved or are being developed, including mRNA vaccines. China has also been in talks regarding Germany’s BioNTech mRNA vaccine for some time.
The fact that the Chinese regulator could swiftly approve Pfizer’s Covid-19 oral drug Paxlovid in February last year, months after the drug was approved in the United States, is surely proof that loss of face has nothing to do with lack of Chinese approval for Western mRNA vaccines.
Advertisement

The United States has long been realistic in setting foreign policy. Given that its offer of vaccine help is in service of its political agenda, it is unlikely that China’s acceptance of American assistance would improve the bilateral relationship.

Advertisement
Select Voice
Choose your listening speed
Get through articles 2x faster
1.25x
250 WPM
Slow
Average
Fast
1.25x